Page last updated: 2024-10-26

disopyramide and Aortic Stenosis, Subvalvular

disopyramide has been researched along with Aortic Stenosis, Subvalvular in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Aortic Stenosis, Subvalvular: A pathological constriction occurring in the region below the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pollick, C1

Other Studies

1 other study available for disopyramide and Aortic Stenosis, Subvalvular

ArticleYear
Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.
    The New England journal of medicine, 1982, Oct-14, Volume: 307, Issue:16

    Topics: Administration, Oral; Adult; Aortic Stenosis, Subvalvular; Cardiomyopathy, Hypertrophic; Disopyramid

1982